Abstract
Endocarditis is a lethal disease; almost one third of endocarditis patients will need surgical intervention. Each individual patient with endocarditis needs to be carefully assessed for the infectious process and evaluated for valve dysfunction in order to decide when and how to operate. In this chapter, we focus on timing of surgical intervention and illustrating different surgical options for different valvular pathology. Different techniques of valve repair and choices for valve replacement are discussed. Special situation such as prosthetic valve endocarditis and endocarditis in intravenous drug users are also highlighted. Outcomes for surgical intervention for endocarditis are reviewed as well.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Mirabel M, Sonneville R, Hajage D, et al. Long term outcomes and cardiac surgery in critically ill patients with infective endocarditis. Eur Heart J. 2014;35:1195–204.
Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288:75–81.
Tornos P, Iung B, Permanyer-Miralda G, et al. Infective endocarditis in Europe: lessons from the euro heart survey. Heart. 2005;91:571–5.
Chan KL, Dumesnil JG, Cujec B, et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol. 2003;42(5):775–80.
Gil J, Grovas-Abad D. Update on infective endocarditis. P R Health Sci J. 2004;23:293–300.
Lamas C, Eykyn SJ. Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart. 2003;89:258–62.
Richardson DC, Burrows LL, Korithoski B, et al. Tropheryma whippelii as a cause of afebrile culture-negative endocarditis: the evolving spectrum of Whipple’s disease. J Infect. 2003;47:170–3.
Salamand A, Collart F, Caus T, et al. Q fever endocarditis: over 14 years of surgical experience in a referral center for rickettsioses. J Heart Valve Dis. 2002;11:84–90.
Mesana T, Collart F, Caus T, et al. Q fever endocarditis: a surgical view and a word of caution. J Thorac Cardiovasc Surg. 2003;125:217–8.
Bayer A, Bolger A, Taubert K, et al. Diagnosis and management of infective endocarditis and its complications. Circulation. 1998;98:2936–48.
Bruun NE, Habib G, Thuny F, et al. Cardiac imaging in infectious endocarditis. Eur Heart J. 2014;35:624–32.
Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis: the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European society of cardiology (ESC). Eur Heart J. 2009;30:2369–413.
d’Udekem Y, David T, Feindel C, et al. Long-term results of operation for paravalvular abscess. Ann Thorac Surg. 1996;62:48–53.
Nishimura RA, Otto CM, Bonow RO, American college of Cardiology/AmericanHeart Association Task Force on Practice Guidelines, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):2438–88.
Tornos P, Almirante B, Mirabet S, Permanyer G, Pahissa A, Soler-Soler J. Infective endocarditis due to staphylococcus aureus deleterious effect of anticoagulant. Therapy Arch Intern Med. 1999;159(5):473–5.
Chertow G, Levy E, Hammermeister K, et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343–8.
Thuny F, Grisoli D, Collart F, et al. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379:965–75.
Remadi J, Najdi G, Brahim A, et al. Superiority of surgical versus medical treatment in patients with Staphylococcus aureus infective endocarditis. Int J Cardiol. 2005;99:195–9.
d’Udekem Y, David T, Feindel C, et al. Long-term results of surgery for active infective endocarditis. Eur J Cardiothorac Surg. 1997;11:46–52.
Saleh A, Dawkins K, Monro J. Surgical treatment of infective endocarditis. Acta Cardiol. 2004;59:658–62.
Sanfilippo A, Picard M, Newell J, et al. Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol. 1991;18:1191–9.
Chan K. Early clinical course and long-term outcome of patients with infective endocarditis complicated by perivalvular abscess. CMAJ. 2002;167(1):19–24.
Choussat R, Thomas D, Isnard R, et al. Perivalvular abscesses associated with endocarditis; clinical features and prognostic factors of overall survival in a series of 233 cases. Perivalvular Abscesses French Multicentre Study. Eur Heart J. 1999;20:232–41.
Baumgartner F, Omari B, Robertson J, et al. Annular abscesses in surgical endocarditis: anatomic, clinical, and operative features. Ann Thorac Surg. 2000;70:442–7.
Blumberg E, Karalis D, Chandrasekaran K, et al. Endocarditis-associated paravalvular abscesses. Do clinical parameters predict the presence of abscess? Chest. 1995;107:898–903.
Piper C, Wiemer M, Schulte H, et al. Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis. 2001;10:703–11.
Steckelberg J, Murphy J, Ballard D, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med. 1991;114:635–40.
Hosono M, Sasaki Y, Hirai H, et al. Considerations in timing of surgical intervention for infective endocarditis with cerebrovascular complications. J Heart Valve Dis. 2010;19(3):321–5.
Matsushita K, Kuriyama Y, Sawada T, et al. Hemorrhagic and ischemic cerebrovascular complications of active infective endocarditis of native valve. Eur Neurol. 1993;33:267–74.
Eishi K, Kawazoe K, Kuriyama Y, et al. Surgical management of infective endocarditis associated with cerebral complications. Multicenter retrospective study in Japan. J Thorac Cardiovasc Surg. 1995;110(6):1745–55.
Thuny F, Beurtheret S, Mancini J, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011;32:2027–33.
Yankah AC, Pasic M, Klose H, et al. Homograft reconstruction of the aortic root for endocarditis with periannular abscess: a 17-year study. Eur J Cardiothorac Surg. 2005;28:69–75.
Wilhelm M, Tavakoli R, Schneeberger K, et al. Surgical treatment of infective mitral valve endocarditis. J Heart Valve Dis. 2004;13:754–9.
Mihaljevic T, Paul S, Leacche M, et al. Tailored surgical therapy for acute native mitral valve endocarditis. J Heart Valve Dis. 2004;13:210–6.
Moon M, Miller D, Moore K, et al. Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg. 2001;71:1164–71.
Riberi A, Caus T, Mesana T, et al. Aortic valve or root replacement with cryopreserved homograft for active infectious endocarditis. Cardiovasc Surg. 1997;5:579–83.
Savage EB, Saha-Chaudhuri P, Asher CR, et al. Outcomes and prosthesis choice for active aortic valve infective endocarditis: analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg. 2014;98(3):806–8014.
Sedgwick JF, Burstow DJ. Update on echocardiography in the management of infective endocarditis. Curr Infect Dis Rep. 2012;14(4):373–80.
Pettersson G, Hussain S, Shrestha N, et al. Infective endocarditis: an atlas of disease progression for describing, staging, coding, and understanding the pathology. J Thorac Cardiovasc Surg. 2014;147(4):1142–9.
Byrne JG, Rezai K, Sanchez JA, et al. Surgical management of endocarditis: the society of thoracic surgeons clinical practice guideline. Ann Thorac Surg. 2011;91:2012–9.
Haydar H, He G, Hovaguimian H, et al. Valve repair for aortic insufficiency: surgical classification and techniques. Eur J Cardiothorac Surg. 1997;11:258–65.
Acar J, Michel P, Varenne O, et al. Surgical treatment of infective endocarditis. Eur Heart J. 1995;16(Suppl B):94–8.
Murashita T, Sugiki H, Kamikubo Y, et al. Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes. Eur J Cardiothorac Surg. 2004;26:1104–11.
Jamieson W, von Lipinski O, Miyagishima R, et al. Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after mitral valve replacement. J Thorac Cardiovasc Surg. 2005;129:1301–8.
Kassai B, Gueyffier F, Cucherat M, et al. Comparison of bioprosthesis and mechanical valves, a meta–analysis of randomised clinical trials. Cardiovasc Surg. 2000;8(6):477–83. Review. Erratum in: Cardiovasc Surg 2001 Jun;9:304–6.
Sweeney M, Reul G, Cooley D, et al. Comparison of bioprosthetic and mechanical valve replacement for active endocarditis. J Thorac Cardiovasc Surg. 1985;90(5):676–80.
Prendergast B, Tornos P. Surgery for infective endocarditis who and when? Circulation. 2010;121:1141–52.
Shirhan A, Sagie A. Tricusped regurgitation in mitral valve disease: incidence, prognostic implications, mechanism and management. J Am Coll Cardiol. 2009;53(5):401–8.
Bedeir K, Readon M, Ramlawi B. Infective endocradtis: perioperative management and surgical principals. JTCVS. 2014;147:1133–41.
Wilson L, Thomas D, Astemborski J, et al. Prospective study of infective endocarditis among injection drug users. J Infect Dis. 2002;185:1761–6.
Mestres C, Chuquiure J, Claramonte X, et al. Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1. Eur J Cardiothorac Surg. 2003;23:1007–16.
Grubitzsch H, Schaefer A, Melzer C, et al. Outcome after surgery for prosthetic valve endocarditis and the impact of preoperative treatment. J Thorac Cardiovasc Surg. 2014;148(5):2052–9.
Sohali M, Martin K, Wilson W, et al. Medical versus surgical management of staphylococcus aurues prosthetic valve endocarditis. Am J Med. 2006;119:147–54.
Delahaye F, Célard M, Roth O, de Gevigney G. Indications and optimal timing for surgery in infective endocarditis. Heart. 2004;90:618–20.
Garzoni C, Nobre VA, Garbino J. Candida parapsilosis endocarditis: a comparative review of the literature. Eur J Clin Microbiol Infect Dis. 2007;26:915–26.
Romano G, Carozza A, Della Corte A, et al. Native versus primary prosthetic valve endocarditis: comparison of clinical features and long-term outcome in 353 patients. J Heart Valve Dis. 2004;13:200–8; discussion 208–9.
Amrani M, Schoevaerdts J, Eucher P, et al. Extension of native aortic valve endocarditis: surgical considerations. Eur Heart J. 1995;16(Suppl B):103–6.
Akowuah E, Davies W, Oliver S, et al. Prosthetic valve endocarditis: early and late outcome following medical or surgical treatment. Heart. 2003;89:269–72.
Habib G, Tribouilloy C, Thuny F, et al. Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases. Heart. 2005;91(7):954–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing
About this chapter
Cite this chapter
Elmistekawy, E., Chan, V., Mesana, T. (2016). Surgical Management: Indications, Timing and Surgical Techniques. In: Chan, KL., Embil, J. (eds) Endocarditis. Springer, Cham. https://doi.org/10.1007/978-3-319-27784-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-27784-4_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27782-0
Online ISBN: 978-3-319-27784-4
eBook Packages: MedicineMedicine (R0)